中文 | English
Return
Total: 52 , 1/6
Show Home Prev Next End page: GO
MeSH:(Pyridines/therapeutic use)

1.Efficacy and Safety of Apatinib in Treating Advanced Colorectal Cancer.

Ning Ning LI ; Jian Feng ZHOU ; Lin ZHAO ; Hong Yan YING ; Ning JIA

Acta Academiae Medicinae Sinicae 2019;41(2):170-174

2.Patients with Metastatic Colorectal Cancer after Failure of Second-Line Treatment May Benefit from Low-Dose Apatinib and S-1 Combined with Jianpi Bushen Jiedu Decoction.

Yue CHEN ; Yu-Ying XU ; Hai-Jun JIANG ; Lei WANG ; Jia-Wei ZHAI ; Tong ZHANG ; Yu-Fei YANG

Chinese journal of integrative medicine 2022;28(10):924-929

4.Therapeutic effects of crizotinib in EML4-ALK-positive patients with non-small-cell lung cancer.

Xuan WU ; Jianxiong LI

Journal of Southern Medical University 2015;35(5):753-757

5.Etoricoxib versus indometacin in the treatment of Chinese patients with acute gouty arthritis: a randomized double-blind trial.

Ting LI ; Shun-le CHEN ; Qing DAI ; Xing-Hai HAN ; Zhan-Guo LI ; Dong-Hai WU ; Xiao ZHANG ; Jie-Ruo GU ; Nan-Ping YANG ; Ling-Yun SUN ; Miu-Jia ZHANG ; Xing-Fu LI ; Chun-de BAO

Chinese Medical Journal 2013;126(10):1867-1871

8.Comparison of preemptive analgesia efficacy between etoricoxib and rofecoxib in ambulatory gynecological surgery.

Wei LIU ; C C LOO ; H M TAN ; Tie-Hu YE ; Hong-Zhi REN

Acta Academiae Medicinae Sinicae 2004;26(6):666-670

10.Sorafenib for advanced hepatocellular carcinoma: a systematic review.

Zou LING-LIN ; Ma LI ; Tian JIN-HUI ; Yang KE-HU

Acta Academiae Medicinae Sinicae 2011;33(1):51-57

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 52 , 1/6 Show Home Prev Next End page: GO